HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Birte K Skrumsager Selected Research

Biomarkers (Surrogate Marker)

6/2007An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Birte K Skrumsager Research Topics

Disease

3Melanoma (Melanoma, Malignant)
03/2009 - 06/2007
2Neoplasms (Cancer)
10/2008 - 06/2007
1Rheumatoid Arthritis
04/2016
1Autoimmune Diseases (Autoimmune Disease)
03/2009
1Renal Cell Carcinoma (Grawitz Tumor)
10/2008
1Fever (Fevers)
06/2007
1Dizziness (Lightheadedness)
06/2007
1Fatigue
06/2007
1Neutropenia
06/2007
1Thrombocytopenia (Thrombopenia)
06/2007
1Abdominal Pain (Pain, Abdominal)
03/2002
1Leukorrhea
03/2002
1Headache (Headaches)
03/2002

Drug/Important Bio-Agent (IBA)

3interleukin-21 (interleukin 21)IBA
03/2009 - 06/2007
1Monoclonal AntibodiesIBA
04/2016
1InterleukinsIBA
04/2016
1CytokinesIBA
10/2008
1Alanine Transaminase (SGPT)IBA
06/2007
1AntibodiesIBA
06/2007
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2007
1Biomarkers (Surrogate Marker)IBA
06/2007
1levormeloxifeneIBA
03/2002

Therapy/Procedure

2Therapeutics
03/2009 - 06/2007
1Aftercare (After-Treatment)
06/2007